CELU: Celularity Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 66.00
Enterprise Value ($M) 66.00
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.50
Return on Equity (ROE) -1.17

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-15 13D/A Dragasac Ltd 34.20 -89.64
02-08 13G/A UNITED THERAPEUTICS Corp 4.11 0.00
10-05 13G/A Sorrento Therapeutics, Inc. 2.60 -75.27

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-01-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-22 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 4,197 8,505 49.35
2024-04-30 4,747 11,290 42.05
2024-04-29 6,974 5,061 137.80

(click for more detail)

Similar Companies
CDMO – Avid Bioservices, Inc. CDTX – Cidara Therapeutics, Inc.
CDXC – ChromaDex Corporation CELZ – Creative Medical Technology Holdings, Inc.
CERE – Cerevel Therapeutics Holdings, Inc.


Financial data and stock pages provided by
Fintel.io